Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000.

V Stambos, K A Brussen, A Turnbull, B Thorley, M Kennett
{"title":"Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000.","authors":"V Stambos, K A Brussen, A Turnbull, B Thorley, M Kennett","doi":"10.33321/cdi.2001.25.11","DOIUrl":null,"url":null,"abstract":"<p><p>The Australian National Polio Reference Laboratory at the Victorian Infectious Diseases Reference Laboratory (VIDRL) is responsible for processing and testing samples for poliovirus from all Australian patients with acute flaccid paralysis and for identifying and characterising polioviruses recovered from untyped enteroviruses submitted from Australian laboratories. From 1 July to 31 December 2000, a total of 12 specimens from 7 patients with AFP were referred to the NPRL. Poliovirus type 3 Sabin-like was isolated from samples from 2 patients with suspected vaccine- associated paralytic poliomyelitis. No viruses were isolated from samples from the remaining 5 patients. Since 1995 a total of 1,325 isolates have been referred for testing from laboratories throughout Australia. Seven hundred (53%) were confirmed as Sabin vaccine-like polioviruses, 542 (41%) were non-polio enteroviruses and 82 (6%) yielded no virus or viruses other than enteroviruses. At Kyoto, Japan in October 2000, the Western Pacific Region of the World Health Organization was declared wild polio-free. This represents a significant step towards the global eradication of poliovirus with one quarter of the world's population free of endemic infections from wild poliovirus. Surveillance of AFP and containment of wild polioviruses has been coordinated at the VIDRL. Since February 2000, Australia has been developing and implementing a plan for the containment of wild poliovirus stocks and potentially infectious materials.</p>","PeriodicalId":520897,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":"25 2","pages":"54-8"},"PeriodicalIF":0.0000,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable diseases intelligence quarterly report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33321/cdi.2001.25.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The Australian National Polio Reference Laboratory at the Victorian Infectious Diseases Reference Laboratory (VIDRL) is responsible for processing and testing samples for poliovirus from all Australian patients with acute flaccid paralysis and for identifying and characterising polioviruses recovered from untyped enteroviruses submitted from Australian laboratories. From 1 July to 31 December 2000, a total of 12 specimens from 7 patients with AFP were referred to the NPRL. Poliovirus type 3 Sabin-like was isolated from samples from 2 patients with suspected vaccine- associated paralytic poliomyelitis. No viruses were isolated from samples from the remaining 5 patients. Since 1995 a total of 1,325 isolates have been referred for testing from laboratories throughout Australia. Seven hundred (53%) were confirmed as Sabin vaccine-like polioviruses, 542 (41%) were non-polio enteroviruses and 82 (6%) yielded no virus or viruses other than enteroviruses. At Kyoto, Japan in October 2000, the Western Pacific Region of the World Health Organization was declared wild polio-free. This represents a significant step towards the global eradication of poliovirus with one quarter of the world's population free of endemic infections from wild poliovirus. Surveillance of AFP and containment of wild polioviruses has been coordinated at the VIDRL. Since February 2000, Australia has been developing and implementing a plan for the containment of wild poliovirus stocks and potentially infectious materials.

澳大利亚国家脊髓灰质炎参考实验室报告,2000年7月1日至12月31日。
维多利亚州传染病参考实验室(VIDRL)的澳大利亚国家脊髓灰质炎参考实验室负责处理和检测所有澳大利亚急性弛缓性麻痹患者的脊髓灰质炎病毒样本,并确定从澳大利亚实验室提交的未分型肠病毒中恢复的脊髓灰质炎病毒并确定其特征。从2000年7月1日至12月31日,共有7例AFP患者的12份标本被转介到NPRL。从2例疑似疫苗相关性麻痹性脊髓灰质炎患者的样本中分离到3型沙宾样脊髓灰质炎病毒。从其余5例患者的样本中未分离到病毒。自1995年以来,澳大利亚各地的实验室共对1,325个分离株进行了检测。700例(53%)被确认为Sabin疫苗样脊髓灰质炎病毒,542例(41%)为非脊髓灰质炎肠病毒,82例(6%)未产生病毒或除肠病毒以外的病毒。2000年10月在日本京都,世界卫生组织宣布西太平洋区域无野生脊髓灰质炎。这是朝着全球消灭脊髓灰质炎病毒迈出的重要一步,世界上四分之一的人口不再受到野生脊髓灰质炎病毒的地方性感染。小儿麻痹性弛缓性麻痹监测和遏制野生脊髓灰质炎病毒已在VIDRL得到协调。自2000年2月以来,澳大利亚一直在制定和实施一项计划,以遏制野生脊髓灰质炎病毒库存和潜在传染性物质。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信